Our colleagues Emelia Benjamin, Renate Schnabel and Isabelle C. Van Gelder has spearheaded this report from the U.S. National Heart, Lung, and Blood institute. It gives a nice overview of the current status of AF screening and highlights the knowledge gaps in an elegant way: “(1) role of opportunistic screening; (2) AF as a risk factor, risk marker, or both; (3) relationship between AF burden detected with long-term monitoring and outcomes/treatments; (4) designs of potential randomized trials of systematic AF screening with clinically relevant outcomes; and (5) role of AF screening after ischemic stroke.”
Read the full article here.
Categories: NEWS
Leave a Reply